Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)

Autor: Guisado-Vasco, Pablo ^{a, ⁎}, Valderas-Ortega, Sofia ^b, Carralón-González, Maria Maravillas ^a, Roda-Santacruz, Ana ^c, González-Cortijo, Lucia ^d, Sotres-Fernández, Gabriel ^a, Martí-Ballesteros, Eva María ^e, Luque-Pinilla, José Manuel ^a, Almagro-Casado, Elena ^d, La Coma-Lanuza, Félix J. ^f, Barrena-Puertas, Ruth ^a, Malo-Benages, Esteban Javier ^g, Monforte-Gómez, María José ^h, Diez-Munar, Rocío ⁱ, Merino-Lanza, Esther ^j, Comeche-Casanova, Lorena ^k, Remirez-de-Esparza-Otero, Margarita ^l, Correyero-Plaza, María ^m, Recio-Rodríguez, Manuel ⁿ, Rodríguez-López, Margarita ^o, Sánchez-Manzano, María Dolores ^a, Andreu-Vázquez, Cristina ^p, Thuissard-Vasallo, Israel John ^p, María-Tomé, José María Echave-Sustaeta ^k, Carnevali-Ruiz, Daniel ^a

Publikováno v: In EClinicalMedicine November 2020 28

Impact of COVID-19 infection on genitourinary cancer management. SOGUG-COVID-19: A spanish, multicenter, observational study.

Autor: Vidal N; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain., Climent MÁ; Medical Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain., Pérez S; Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Méndez-Vidal MJ; Maimonides Institute for Biomedical Research of Córdoba (IMIBIC) Hospital Universitario Reina Sofía, Medical Oncology Department, Córdoba, Spain., Anguera G; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Martínez Salas I; Medical Oncology Department, Fundación Jiménez Díaz, Madrid, Spain., Gallardo E; Medical Oncology Department, Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain., Cuéllar-Rivas MA; Medical Oncology Department, Institut Català d'Oncologia (ICO) L'Hospitalet del Llobregat, Barcelona, Spain., Molina-Cerrillo J; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Martín A; Medical Oncology Department, Hospital Universitario Infanta Leonor, Madrid, Spain., Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar, IMIM Research Institute, CIBERONC, Barcelona, Spain., Almagro Casado E; Medical Oncology Department, Hospital Universitario Quirón Salud Madrid, Pozuelo de Alarcón, Spain., Gonzalez M; Medical Oncology Department, Vall d´Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d´Hebron, Barcelona, Spain., Domènech M; Medical Oncology Department, Fundación Althaia, Manresa, Spain., Martínez Kareaga M; Medical Oncology Department, Hospital Txagorritxu, Vitoria Gasteiz, Spain., Fernández Calvo O; Medical Oncology Department, Complejo Hospitalario Universitario de Ourense, Ourense, Spain., Villa Guzmán JC; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Vázquez Estévez S; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain., González-Del-Alba A; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, C/Joaquin Rodrigo 2, Majadahonda, 28222, Madrid, Spain. aranzazu.gonzalezalba@salud.madrid.org., Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Oct 06. Date of Electronic Publication: 2024 Oct 06.